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Summary
Siderocalin, a member of the lipocalin family of bind-
ing proteins, is found in neutrophil granules, uterine
secretions, and at markedly elevated levels in serum
and synovium during bacterial infection; it is also
secreted from epithelial cells in response to inflam-
mation or tumorigenesis. Identification of high-affin-
ity ligands, bacterial catecholate-type siderophores
(such as enterochelin), suggested a possible function
for siderocalin: an antibacterial agent, complement-
ing the general antimicrobial innate immune system
iron-depletion strategy, sequestering iron as ferric
siderophore complexes. Supporting this hypothesis,
siderocalin is a potent bacteriostatic agent in vitro
under iron-limiting conditions and, when knocked out,
renders mice remarkably susceptible to bacterial infec-
tion. Here we show that siderocalin also binds soluble
siderophores of mycobacteria, including M. tubercu-
losis: carboxymycobactins. Siderocalin employs a de-
generate recognition mechanism to cross react with
these dissimilar types of siderophores, broadening the
potential utility of this innate immune defense.
Introduction
Lipocalins are a functionally diverse group of binding
proteins, widely expressed across multiple phyla, that
share a conserved structure even in the absence of sig-
nificant sequence conservation (Flower et al., 2000).
This core structure consists of an eight-stranded anti-
parallel β barrel that defines a calyx, or cup-shaped
structure, enclosing the ligand binding site, plus con-
served α and 310 helices (Flower, 1996). The loops link-
ing the β strands are typically short β hairpins, except
the first loop, which describes a large  loop that usu-
ally folds back onto the barrel, partially constricting the
binding site. Lipocalins generally act as transporters
(though some are enzymes), trafficking small molecules
to specific cells and are thus proposed to be variously
involved in retinol transport, invertebrate cryptic color-*Correspondence: rstrong@fhcrc.orgation, olfaction, pheromone transport, fatty acid trans-
port, prostaglandin synthesis, modulation of cell growth
and metabolism, regulation of the immune response, tis-
sue development, and animal behavior (Åkerstrom et
al., 2000a). Lipids or lipophilic molecules are common
candidate ligands, hence the name “lipocalin,” re-
flected in the apolar character of the lining of the calyx,
generally a deep invagination into the protein core.
Siderocalin (Lipocalin 2) is deposited in late granules
in neutrophil precursors and can be expressed highly
in a variety of tissues, particularly epithelium (Kjeldsen
et al., 2000). An acute phase protein in mice, siderocalin
concentrations rise dramatically in serum (where its
presence diagnostically differentiates between bacte-
rial and viral infections [Xu and Venge, 2000]) and other
bodily fluids in response to inflammatory signals or in-
fection (Kjeldsen et al., 2000). Siderocalin has histori-
cally been variously referred to as neutrophil gelatinase
associated lipocalin (NGAL), human neutrophil lipocalin
(HNL), α1-microglobulin related protein (human or-
tholog); 24p3, uterocalin, superinducible protein 24
(SIP24; murine ortholog); or neu-related lipocalin (NRL;
rat ortholog) (Kjeldsen et al., 2000). Unlike the stereo-
typical lipocalin, structure determinations show that
siderocalin has a broad, shallow calyx lined with polar
and positively charged residues (Coles et al., 1999;
Goetz et al., 2000, 2002). Siderocalin has been shown
to specifically bind, with a subnanomolar dissociation
constant (Goetz et al., 2002), the phenolate/cate-
cholate-type enterobacterial ferric siderophore entero-
chelin (Raymond et al., 2003) (FeEnt, or Ent in its apo
form, also referred to as enterobactin; Figure 1). Sidero-
phores are low molecular weight (500–1000 Da), virtu-
ally ferric-specific chelators involved in microbial iron
acquisition (Stintzi and Raymond, 2002; Winkelmann,
2002). Siderocalin is therefore proposed to function by
complementing the general antibacterial iron-seques-
tration strategy of the innate immune system (Goetz et
al., 2002). Siderocalin uniquely complements this strat-
egy by binding iron already earmarked for bacterial use
through its specificity for ferric siderophore complexes,
rather than binding iron directly (Goetz et al., 2002), as
does, for example, the bacteriostatic protein lactoferrin.
Consistent with this proposal, siderocalin is a potent
bacteriostatic agent in vitro under iron-limiting culture
conditions (Goetz et al., 2002); siderocalin knock-out
mice, in the absence of any other gross morphological,
behavioral, or physiological defects, are also pro-
foundly susceptible to bacterial infections with clinical
isolates of E. coli (Flo et al., 2004). Both effects are due
to the limitation of bacterial growth through iron deple-
tion. Several studies have demonstrated the impor-
tance of such tissue- and pathogen-specific antimicro-
bial proteins in other systems. Human defensins and
mouse cryptdins, secreted by Paneth cells in small in-
testinal crypts, provide protection against enteropatho-
genic Salmonella (Salzman et al., 2003; Wilson et al.,
1999); mice deficient in the cathelicidin CRAMP, pro-
duced by neutrophils and skin keratinocytes, are more
susceptible to cutaneous infections of group A strepto-
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30Figure 1. Siderocalin Binding Preference for Representative Siderophores
Compounds demonstrating tight binding in qualitative SPR-based (reported here or in Flo et al., 2004) or quantitative fluorescence quenching
(Goetz et al., 2002) assays are boxed. Compounds are grouped by similar iron liganding chemistry: solely DHBA-based phenolate/cate-
cholates (Ent through MECAM), mixed phenolates (TRENCAM-3,2-HOPO and parabactin), mixed phenolate/hydroxamates (CMBs), hydroxa-
mates (fusigen through ferrioxamine), mixed hydroxamate/α-hydroxycarboxylic acid (aerobactin), α-hydroxycarboxylic acids (rhizoferrin), and
the complex siderophores of Pseudomonas: pyochelin and pyoverdin. Iron ligands are shown in bold.
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31cocci (Nizet et al., 2001). However, the molecular mech-
anisms of these latter defenses remain to be fully eluci-
dated.
While human siderocalin also associates, through a
specific disulfide linkage, with matrix metalloprotein-
ase-9 (MMP-9; also gelatinase B) in neutrophil granules
(Kjeldsen et al., 2000), the only demonstrated conse-
quence is a slight acceleration of the direct activation
of promatrix metalloproteinases through a nonphysio-
logical pathway (Tschesche et al., 2001). There is no
noncovalent component to siderocalin/MMP-9 associ-
ation (M.A.H., unpublished data), suggesting that the
interaction may be serendipitous (murine siderocalin
lacks the corresponding cysteine and is not known to
associate with MMP-9). Murine siderocalin has also
been implicated in processes as diverse as apoptosis
(Devireddy et al., 2001), though the effect has only been
demonstrated in a limited context (Kamezaki et al.,
2003), and kidney cell differentiation (Yang et al., 2002),
functioning through a transferrin-independent iron
transport pathway by binding an endogenous, currently
uncharacterized, mammalian “siderophore.” Human-
mouse-rat siderocalin pair-wise sequence identities are
60%–81%, where the pattern of conservation strongly
implies conservation of ligand specificity (Goetz et al.,
2002); no other obvious orthologs have been identified
so far.
Here we show that unusual aspects of the sidero-
calin/siderophore recognition mechanism, dominated
by hybrid electrostatic/cation-π interactions, permit de-
generate recognition of (1) a range of catecholate sid-
erophores chemically similar to Ent and (2) the soluble
siderophores of mycobacteria, carboxymycobactins
(CMBs), which are chemically distinct from Ent. (CMBs
were originally referred to as “exochelins,” though that
term is now reserved for distinct, soluble siderophores
of saprophytic mycobacteria [Figure 1].) The conse-
quence of these results is broadening potential sidero-
calin-mediated antibacterial innate immune responses
to include a wide array of pathogens. Defining the
specificity of siderophore binding innate immune sys-
tem components has additional implications for the as-
sociation of certain siderophores with virulence and for
proposals to use siderophores and siderophore ana-
logs as therapeutics (Budzikiewicz, 2001; Horwitz et al.,
1998; Roosenberg et al., 2000).
Results
Previous crystallographic studies of siderocalin showed
that the protein recognizes FeEnt through a novel hy-
brid of ionic (Ent is uncharged, but FeEnt carries a net
−3 charge [Raymond et al., 1984] delocalized over the
molecule [Goetz et al., 2002]) and cation-π interactions,
where the interacting groups are interlaced, alternating
between cationic moieties and catecholates, in a cycli-
cally permuted manner around the iron atom (Goetz et
al., 2002) (Figures 2A and 3A). Cation-π bonds in pro-
teins are interactions between the positive charge of
lysine or arginine side chains and the quadrupole mo-
ment associated with the delocalized π electrons of an
aromatic functional group such as tryptophan, tyrosine,
or phenylalanine (Dougherty, 1996). In siderocalin, thecationic groups are donated by the side chains of three
positively charged residues, Arg81, Lys125, and Lys134.
The KD for the interaction was measured at 0.4 nM at
22°C by fluorescence quenching (Goetz et al., 2002).
The nature of siderocalin/siderophore interactions,
where the siderophore is centered in the siderocalin ca-
lyx making multiple, direct, polar interactions, together
with the tight affinity, clearly demonstrate specificity
and is almost certainly not serendipity.
However, the structural analysis revealed two un-
usual aspects of the complex: (1) the quality of the
electron density corresponding to the siderophore in all
three monomers of the asymmetric unit was very poor,
diffuse, and choppy; and (2) the fit of the siderophore
into the calyx exposed much of the ligand to solvent
and failed to fill several obvious, underlying pockets.
The quality of the ligand electron density was so poor
that FeEnt was best modeled as multiple conforma-
tions of partial structures representing FeEnt hydrolysis
products, dihydroxybenzoic acid (DHBA), and serine-
dihydroxybenzoate (DHBS), though intact FeEnt was
also refined separately (Goetz et al., 2002) (Figure 2A).
There are several possible explanations for the poor
quality of the ligand density in an otherwise well-refined
structure: (1) degradation of FeEnt, through hydrolysis
and/or oxidation in solution, during the course of crys-
tallization (almost 7 months); (2) less-than-complete li-
gand occupancy; and (3) ligand mobility; or some com-
bination of these factors. The failure of FeEnt to
completely fill the calyx also raised the possibility that
siderocalin may also bind other ligands. Siderophores
come in a bewildering array of variants that can be di-
vided into three broad classes depending on the chem-
istry of chelation: hydroxamates, phenolates/catecho-
lates, or α-hydroxycarboxylates (Figure 1)—though
examples of yet other iron binding moieties are known.
Therefore, the possibility exists that siderocalin may
bind siderophores other than phenolate/catecholates,
which would potentially broaden the range of affected
pathogens.
Siderocalin Binding Does Not Constrain Phenolate
Siderophores to a Defined Orientation
In order to control for ligand degradation, new crystalli-
zation conditions were found that yielded diffraction-
quality crystals within weeks rather than months and at
a lower pH (see Experimental Procedures). This new
crystal form is nearly isomorphous with the neutral pH
siderocalin/FeEnt complex crystals, with three mole-
cules (A, B, and C) in the asymmetric unit. Siderocalin
was also cocrystallized with two synthetic sidero-
phores: TRENCAM, an analog of Ent, and TRENCAM-
3,2-HOPO, similar to the natural siderophore cepabac-
tin which contains a 1,2-hydroxypyridinone (HOPO) iron
binding moiety (Figure 1 and Table 1) (Thulasiraman et
al., 1998). HOPO moieties also reduce the net negative
charge by one relative to DHBA groups, demonstrating
that conservation of an overall net charge of −3 is not
a requirement for siderocalin binding. These synthetic
compounds, with different backbone chemistries, are
far more resistant to hydrolysis in solution than natural
siderophores with labile triserine trilactone backbones
(Ecker et al., 1988, 1986; Matzanke et al., 1986). Ex-
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32Figure 2. Stereoviews of Siderocalin Ligands Positioned in the Siderocalin Calyx
(A) Ent, (B), CMB-S, and (C), NCA. Ligands are shown in a licorice stick representation, colored by atom-type (C, gray; N, blue; O, red; Fe,
dark red). The molecular surface of the protein (as displayed by SwissPDBViewer [Guex and Peitsch, 1997]) is shown, colored by electrostatic
potential (positive, blue; negative, red). Surfaces corresponding to Trp79, Arg81, Lys125, and Lys134 are labeled. In these views, the three
pockets of the trilobate siderocalin calyx are 1, at the top; 2, at the lower right; and 3, at the lower left. The deepest portion of the calyx is
pocket 2.
(D and E) Stereoviews of superpositions (based only on protein atoms) of all of the different models of Ent and TRENCAM-3,2-HOPO (intact
and partial structures) and the six total CMB-S/T models. The arrowhead indicates the position of the R4 methyl group, the only difference
observed between the CMB-S and -T ligands in the complex crystal structures.
(F) Stereoview of the superposition of key ligand contacting side chains from the 15 available views of siderocalin from the crystal structures,
colored by the ligand present in the complex (NCA or none, blue; phenolate-type siderophore, red; and CMBs, orange). The position of the
iron atom varies by over 1.1 Å among the phenolate-type siderophore calyces and by no more than 0.46 Å among the CMB calyces. All
molecular figures were generated with SwissPDBViewer (Guex and Peitsch, 1997) and rendered using the MegaPOV extensions (megapov.
inetart.net) to POV-Ray (www.povray.org) except where noted.aminations of the preliminary electron density maps, T
sphased by molecular replacement (dmin = 2.5 or 2.1 Å,
respectively), showed that the density corresponding to (
pthe ligands was as poor as in the initial FeEnt complex
(data not shown). The conclusion is that while ligand g
Tdegradation may contribute to poor ligand density, it
does not solely account for the effect. The TRENCAM f
ecomplex was therefore not refined, as the interaction
with siderocalin appeared identical to FeEnt, though t
sthe TRENCAM-3,2-HOPO complex structure was fully
refined (Table 1), as this compound represents a dis- a
itinct siderophore type, again modeling the ligand using
multiple substructures (dihydroxybenzamide). However, l
within the limitation of the poor quality of the density,RENCAM-3,2-HOPO apparently also interacts with
iderocalin identically to FeEnt (Figures 2A and 2D).
The quality of the density did not permit resolving the
referred position, if any, of the asymmetrical HOPO
roup of TRENCAM-3,2-HOPO in the siderocalin calyx.)
he conservation of ligand orientation in the calyx con-
irms the observation that the “backbone” of the sid-
rophore, which is completely different between the na-
ive and synthetic molecules, does not contribute
ignificant protein contacts affecting binding (Goetz et
l., 2002). This point is also supported by the high-affin-
ty binding of MECAM, yet another synthetic Ent ana-
og, with a third, distinct backbone structure (Figure 1).
Though the current complex crystallization condi-
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33Figure 3. Binding of CMB-S to Siderocalin
(A and B) Stereoviews ([A], from the side; [B], from above, looking down into the calyx) of CMB-S bound to siderocalin. The protein is
represented by a superposition of the Cα backbones of all fifteen independent views of siderocalin (from a total of six crystal structures,
three reported here and three previously reported [Goetz et al., 2000, 2002]), colored by secondary structure (α, orange; β, green; and
coil, gray). N termini are colored blue; C termini are colored red; the Cα of Asn65, the location of the single N-linked oligosaccharide, is
colored yellow.
(C) Stereoview of the simulated annealing composite-omit 2Fobs − Fcalc electron density map contoured around the CMB-S ligand (molecule
C; C, gray; N, blue; and O, red) at 1σ (amber) and 8σ (dark red).tions are at low pH (4.5), rather than neutrality, there is
essentially no effect on the overall structure of the pro-
tein (Figures 3A and 3B). Catecholate-type sidero-phores are known to undergo a sequential shift in bind-
ing mode in solution, from phenolate-mode binding to
salicylate-mode binding, concurrent with acidification,
Structure
34Table 1. Crystallographic Statistics
Siderophore TRENCAM-3,2-HOPO TRENCAM CMB-S CMB-T
Data Collection
Space group P41212 P41212 P41212 P41212
Lattice constants (Å) a = b = 114.4, c = 119.0 a = b = 115.1, c = 119.5 a = b = 114.2, c = 119.3 a = b = 114.8, c = 119.1
Resolution range (Å) 20.0–2.10 (2.14–2.10)a 20.0–2.50 (2.54–2.50) 20.0–2.10 (2.14–2.10) 20.0–2.20 (2.24–2.20)
Observations 456,603 204,054 381,305 418,554
Unique reflections 45,047 27,376 46,438 40,016
Completeness (%) 96.6 (93.0) 96.4 (98.4) 99.9 (100.0) 97.6 (99.4)
I/σ(I) 11.1 (1.5) 10.6 (2.8) 16.0 (2.9) 14.6 (2.6)
Rsym (%) 4.7 (39.9) 5.7 (41.3) 5.5 (34.5) 6.8 (37.5)
Fe peak heightsb (A, B, C; σ) 9, 4, 6 11, 7, 14 11, 12, 17 17, 12, 18
Refinement Statistics
Rwork (%) 22.5 — 22.0 22.0
Rfreec (%) 25.7 — 25.1 25.3
Number of atoms
Protein 4,127 — 4,154 4,113
Siderophore 58 — 162 159
Waters 116 — 95 105
Estimated coordinate errord (Å) 0.24 — 0.20 0.23
Geometry
Rmsd bonds (Å) 0.024 — 0.027 0.024
Rmsd angles (°) 2.2 — 2.2 2.2
Rmsd dihedrals (°) 27.5 — 27.3 27.2
Rmsd impropers (°) 1.4 — 1.6 1.4
Average B factor (Å2) 38.3 — 38.3 37.1
Protein monomer B factors 33.3, 50.2, 28.8 33.9, 51.9, 27.2 31.9, 52.8, 26.1
(A, B, C; Å2) —
Siderophore B factors 72.1, 85.6, 61.3 — 47.5, 59.2, 39.1 38.2, 59.0, 36.5
(A, B, C; Å2)
Water B factors (Å2) 36.0 — 33.1 32.2
Ramachandrane
Most favored (%) 90.2 — 90.7 90.5
Additional allowed (%) 8.4 — 7.9 8.0
Generously allowed (%) 0.0 — 0.0 0.5f
Disallowed (%) 1.3f — 1.4f 1.1f
a Numbers in parentheses correspond to the highest resolution shell.
b Peak heights of electron density features associated with ligand iron atoms in simulated annealing composite-omit Fourier syntheses.
c Calculated on 10% of the data (Kleywegt and Brunger, 1996) and matched between data sets.
d Crossvalidated σA error as calculated in CNS (Brunger et al., 1998).
e Calculated with PROCHECK (Laskowski et al., 1992).
f The Ramachandran outliers are the same two residues (Y115 and C175) in all three molecules in all of the refined structures, despite careful
rebuilding, arguing that these residues are not poorly modeled but truly adopt unfavorable conformations.correlating with reduced iron affinity (Cohen and Ray- 2
amond, 2000). The transition occurs one phenolate
group at a time as pH decreases. FeEnt starts to shift i
aat around a pH of 4.5. While poor, the electron density
is good enough to argue that both TRENCAM and t
oTRENCAM-3,2-HOPO remain in phenolate mode in the
complex, suggesting that complexation with sidero- c
ecalin stabilizes phenolate-mode iron binding. The ob-
served iron location, which is well determined in all of u
cthe structures, also constrains the siderophore to a po-
sition in the calyx sterically incompatible with salicyl- r
cate-mode binding.
In order to confirm that the ligands are fully, or near l
cfully, occupied, simulated-annealing composite-omit
maps were calculated in CNS (Brunger et al., 1998), w
fstrictly excluding all ligand atoms. The peak heights of
the electron density features corresponding to the iron F
2atoms (Table 1) are high enough to eliminate low ligand
occupancy as contributing to poor ligand density. l
t(Siderocalin shows no appreciable affinity for iron in any
form in the absence of a siderophore [Goetz et al., s002]; therefore, any iron present in the calyx is part of
ferric siderophore complex.) What variation is seen in
ron peak heights correlates well with ligand B factors,
cross or within individual asymmetric units, rather
han reflecting lower iron occupancies in the TRECAM
r TRENCAM-3,2-HOPO complexes versus the CMB
omplexes. Therefore, the poor quality of the ligand
lectron density is likely mostly a consequence of un-
sually pronounced ligand mobility. This conclusion is
ompatible with the very tight KD in that the siderocalin
ecognition mechanism depends on electrostatic and
ation-π interactions with few hydrogen bonds and only
imited van der Waals contacts (Figure 4B). Indeed, the
ationic groups are not even in van der Waals contact
ith any atoms of the ligands. Superposition of all the
ull FeEnt and DHBA/DHBS partial models of FeEnt and
eTRENCAM-3,2-HOPO from the two structures (Figure
D) does reveal that the most constrained parts of the
igands are the catecholate moieties in pocket 1 of the
rilobate calyx. This pocket, defined by the two lysine
ide chains (125 and 134) contributing cation-π bonds,
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35Figure 4. Exploded LIGPLOT Schematics of the Interactions between Siderocalin and Ent, CMB-S/T, and NCA, Broken Down by Calyx Pocket
(A) Ent, (B) CMB-S/T, and (C) NCA. The pictured interactions represent the union of all the protein/ligand interactions observed across all the
complexes in the asymmetric unit. Ligand covalent bonds are colored purple; protein covalent bonds are colored orange. Hydrogen bonds
are indicated with dashed green lines; cation-π interactions are indicated by dashed yellow bars. Atoms are colored by type (C, black; O, red;
N, blue; and Fe, green). Van der Waals contacts are indicated by red sunbursts. Chemical structures for CMB (the predominant variant
observed in the CMB-S crystal structures) and NCA are also shown; CMB substituent groups (1, the cyclic hydroxamate; 2, the oxazoline; 3,
the phenolate; 4, the linear hydroxamate; and 5, the fatty acid tail) are numbered on the chemical structure and the corresponding parts of
the LIGPLOT diagram for clarity.is thus revealed as likely the key pocket for binding
phenolate-type siderophores.
Siderocalins Bind a Variety of Phenolate
and CMB Siderophores
In order to address whether siderocalin could bind fer-
ric siderophores other than FeEnt, a panel of 18 addi-
tional, representative, natural and synthetic sidero-phores was qualitatively tested for binding by surface
plasmon resonance (SPR), copurification and, when
possible, confirmed by cocrystallization and the pres-
ence of a fully or near-fully occupied iron peak (Table
1). While the SPR assay remains a quick, simple and
powerful method to qualitatively test for ligand binding,
fitting the kinetic data to model binding curves remains
challenging due to the complexity of the multiphasic
Structure
36association and dissociation phases (data not shown). m
pThe slow component/s of the dissociation phase also
prevent the system from achieving equilibrium within a a
treasonable time, precluding the estimation of KD from
equilibrium responses. Siderophores negative for sidero- E
calin binding in the SPR assay also fail to bind when
soaked in excess with the protein at millimolar concen- i
htrations; resultant concentrated protein solutions are
unchanged in color after washing (data not shown). c
EThese results show that, as expected, siderocalin binds
to a family of phenolate/catecholate siderophores chemi- e
hcally related to Ent but not to yeast and bacterial sid-
erophores based on hydroxamate or α-hydroxycarbox- p
cylate iron binding groups. However, quite unexpectedly,
siderocalin also binds the heterogeneous, mixed-type, e
msoluble carboxymycobactin siderophores of Mycobac-
terium smegmatis (CMB-S) and M. tuberculosis (CMB-T) f
C(Gobin et al., 1995; Lane et al., 1998, 1995; Wong et al.,
1996). These compounds are quite distinct chemically m
Tfrom FeEnt and its relatives, with iron binding moieties
contributed by 2-hydroxyphenyloxazoline, a seven- t
ncyclic hydroxamate and a linear hydroxamate trailing
off into a fatty acid tail (Figure 1). CMBs vary species s
tto species and within a single species in the length of
the fatty acid tail and by the identity of several substitu- r
cent groups (Figure 1). As predicted from the pattern of
sequence conservation in the calyx, murine siderocalin i
pdisplays an equivalent binding specificity for the panel
of 18 siderophores (data not shown). e
C
dCMBs More Completely Fill the Siderocalin Calyx,
Binding in a Single Orientation
In order to elucidate the details of the interaction be- L
Ttween siderocalin and CMB ligands, complexes be-
tween siderocalin and either FeCMB-S or -T were crys- t
rtallized and analyzed crystallographically at 2.1 or
2.2 Å resolution, respectively (Table 1; Figures 2–4). The t
CFeCMB ligands occupy a volume in the calyx overlap-
ping that of FeEnt, with the 2-hydroxyphenyloxazoline A
ogroup sitting in pocket 1, the cyclic hydroxamate group
sitting in the upper part of pocket 2 and the linear hy- r
odroxamate sitting in pocket 3 (Figure 2B). The fatty acid
tail curls under the rest of the siderophore, crossing v
ffrom pocket 3 into pocket 1, positioning the carboxyl-
ate group into the bottom of pocket 2. Interestingly, the w
pCMB carboxylate essentially superimposes on the car-
boxylate group of an adventitious ligand, tentatively m
tidentified as n-capric acid (NCA), in the original crystal
structure of siderocalin expressed recombinantly in a t
Abaculovirus system (Goetz et al., 2000) (Figures 2C and
3C). Lysines 125 and 134 participate in cation-π bonds c
ito the CMB hydroxybenzoyl moiety completely analo-
gous to those in Ent, with the hydroxybenzoyl of CMB b
bsuperimposing almost identically onto the DHBA moi-
ety of Ent in pocket 1. However, largely due to the orien- C
ptation of the fatty acid tail, CMBs fill the calyx more
completely, generating more extensive hydrogen bond l
cand van der Waals networks (Figure 4). The result is
that the CMB ligands sit fully resolved in the calyx in a 1
ssingle, well-defined orientation (Figures 2E, 3B, and
4C). The most constrained portion of the CMB structure d
dis again the hydroxybenzoyl group sitting in pocket 1.
The iron atoms in the CMB complex structures have soved as much as 2.5 Å up, out of the calyx, from their
ositions in the Ent complexes. The linear hydroxamate
nd the linking elements (“backbone”) of CMB make
he fewest siderocalin contacts, again analogous to the
nt complex.
Binding either CMB-S or CMB-T results in essentially
dentical crystal structures (Figure 2E). Even though
eterogeneous CMB mixtures, isolated directly from
ulture supernatants (Lane et al., 1995; Ratledge and
wing, 1996), were used in cocrystallizations, the
lectron density is clear enough, and the resolution
igh enough, to show that a single molecular species
redominates in the calyx in both complex structures,
orresponding to an aliphatic linker in the fatty acid tail
ight methylene groups long. Deletion of even one
ethylene group from ligand models worsens the re-
inement statistics. The only difference between the
MB-S and -T ligand structures is the absence of the
ethyl group at the R4 position on the CMB-T ligands.
he structures have been refined with a double bond in
he fatty acid tail (between C47 and C48 in the coordi-
ate file) as suggested by the electron density and con-
istent with Rfree values monitored during rebuilding,
hough this assignment is by no means certain at this
esolution. The CMB-T structure clearly seen in the
omplex structures is also one methylene group longer
n the fatty acid tail than previously reported for com-
ounds isolated from M. tuberculosis cultures (Gobin
t al., 1995). It has so far not been possible to purify
MB variants to the homogeneity necessary to test in-
ividual isoforms for binding.
igand-Sensitive Calyx Structural Elements
he only structural elements in the siderocalin calyx
hat display any significant conformational variation in
esponse to the presence or absence of any of the three
ypes of ligands (NCA, phenolate-type siderophores, or
MBs) are the side chains of two residues: Trp79 and
rg81 (Figure 2F). The side chain of Trp79 is either dis-
rdered (modeled as an alanine) or adopts one of three
otamers fairly consistently, progressively moving out
f the way in response to the increasing size of the
arious ligands. In the CMB structures, the most calyx-
illing ligands, Trp79 is oriented parallel to the calyx
all, with the distal nitrogen of the imidazole moiety
ointing outward. Given the difficulty in confidently
odeling arginine side chain conformations, even at
his resolution, the pattern is less clear, though, again,
he side chain of Arg81 adopts various rotamers. The
rg81 side chain can either intercalate between cate-
holate rings in the FeEnt structures, providing cation-π
nteractions, or move away from the ligand, substituted
y the side chain of Trp79 providing alternate herring-
one ring stacking interactions to the ligand. In the
MB structures, the Arg81 side chains also move to
ositions along the calyx wall to accommodate the
arger ligands. All the other calyx residue side chain
onformations are markedly well conserved among the
5 views of the siderocalin structure, including the ly-
ines (125 and 134) donating cation-π bonds to all the
ifferent siderophore ligands. The structure of the or-
ered solvent shell is quite variable across all of the
tructures, consistent with the variable crystallization
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37conditions and crystal contacts, both over the surface
of the protein and within the calyx. Siderophore binding
displaces most of the calyx waters observed in the
empty structures and there are no uniformly conserved
water-mediated protein/ligand interactions.
Discussion
The Siderocalin Fold Is Imperturbable
Pair-wise superposition rmsds (on all common Cαs)
across the 15 siderocalin models (Goetz et al., 2000,
2002) vary from 0.54 to 0.67 Å; these numbers improve
measurably if the most N-terminal two or three resi-
dues, the most variable siderocalin structural element
(Figures 3A and 3B), are excluded. These structures
span two different expression systems, four different
crystallization conditions (from high to low salt and
neutral to low pH), six different packing environments,
the presence or absence of three different ligand
classes, and even the presence or absence of N-linked
oligosaccharide (at Asn65). After the N terminus, the
next greatest flexibility is seen in the loops rimming the
calyx, where even greater variation is typically seen in
other lipocalins (Flower, 1996). The secondary structure
elements, and their relative arrangement, are fully con-
served. This behavior is consistent with observations
that extreme conditions are required to denature sid-
erocalin and release bound siderophores (Goetz et al.,
2002). However, these results directly contradict con-
clusions based on the solution NMR structure of sid-
erocalin (Coles et al., 1999), where structural mobility,
particularly the orientation of the α helix to the β barrel,
was much more marked. We conclude that the sidero-
calin fold is very stable and well defined. Structural sta-
bility extends to the calyx, where the only flexibility of
any significance is seen in the side chains of two resi-
dues, Trp79 and Arg81. While these two side chains
do move to accommodate the presence or absence of
different ligands, the degree of movement is nowhere
near the level of conformational flexibility typically as-
sociated with “induced-fit” recognition mechanisms.
For instance, this level of binding site plasticity is con-
siderably less than the remodeling observed in the li-
gand binding site of the insect ecdysone receptor,
which binds disparate ecdysteroid hormones and non-
steroidal synthetic agonists (Billas et al., 2003). How-
ever, such side chain movements observed in the
siderocalin calyx could account for the multiphasic as-
sociation kinetics seen in the SPR experiments, where
ligand approach, possibly dominated by the electro-
static component of the interaction, is fast, and estab-
lishing the optimal calyx conformation, possibly opti-
mizing the cation-π network, is slow.
Siderocalin Tightly Binds Phenolate/Catecholate
Siderophores without Securely Constraining
Their Orientation, Enabling Degeneracy
By comparing the complex structures of nonhydrolyz-
able phenolate/catecholate siderophores with the
FeEnt complex structure, optimizing crystallization
conditions to minimize crystallization time, and con-
firming ligand occupancy by careful analysis of iron
peak heights, we have shown that the poor quality ofligand electron density features is the result of marked
ligand flexibility, reflecting fundamental aspects of sidero-
calin-mediated recognition of phenolate/catecholate-type
siderophores, and is not an artifact of previous crystallo-
graphic analyses. Siderocalin has evolved a recognition
mechanism that generates tight binding while tolerating
such flexibility, in the absence of interactions to the
most variable element of this class of microbial sidero-
phores, the backbone linker, thus permitting siderocalin
to degenerately interact with a broad range of pheno-
late/catecholate siderophores. Because the siderophore
phenolate moiety determines bound ligand orientation,
and because the most constrained portion of the ligand
sits in pocket 1, we conclude that it is the highly polar-
ized ferric hydroxybenzoyl group that is the key deter-
minant for siderocalin binding and that pocket 1 is the
key binding pocket. Reliance on cation-π bonds to
highly polarized hydroxybenzoyl iron ligands, either in
context of catecholate, 2-hydroxyphenyloxazoline or,
potentially, HOPO groups, complements the degener-
ate siderocalin recognition mechanism, broadening po-
tential responses. These conclusions are confirmed by
the analysis of siderocalin/CMB complexes, where the
2-hydroxyphenyl group superimposes on the pocket 1
catecholate groups of the phenolate/catecholate-type
siderophores, even though the rest of the structures of
these siderophores are essentially completely different.
Variable solvent structures are unlikely to contribute to
degenerate recognition in that there are few water-
mediated interactions. The CMB complex structures do
show that many of the complex calyx features, sub-
pockets irrelevant for the binding of phenolate/cate-
cholate-type enterobacterial siderophores, allow for the
binding of whole different classes of siderophores,
broadening, in this case, potential siderocalin-medi-
ated antibacterial defenses to mycobacteria, which are
significant human pathogens. However, antimycobac-
terial siderocalin responses may be limited by the high
selectivity of siderocalin for a single CMB species, in
terms of fatty acid tail length, in both the CMB-S and
-T complex structures, even though CMB mixtures
were used in the cocrystallizations. While siderocalin
may be able to tolerate binding of CMB variants ± one
or perhaps two methylene groups in the fatty acid moi-
eties, though likely with significant concurrent reduc-
tions in affinity, it seems unlikely that siderocalin could
accommodate the extremes of the reported CMB-S/T
spectrum (Figure 1), at least while retaining the overall
ligand orientation seen in the current cocrystal struc-
tures. The variation seen in CMB structures may, in-
deed, reflect mycobacterial responses to siderocalin-
mediated defenses, evidenced by the obvious success
of mycobacteria as human pathogens. The efficacy of
siderocalin in thwarting mycobacterial infections in vivo
remains to be tested.
Are There Other Siderophore Binding Lipocalins?
While broadly and degenerately recognizing enterobac-
terial phenolate/catecholate siderophores and specifi-
cally interacting with at least a limited spectrum of my-
cobacterial CMBs, siderocalin fails to bind to many
bacterial siderophores and essentially all types of fun-
gal siderophores (Figure 1). It is likely that evading sid-
Structure
38Figure 5. Ribbon Representations of Sidero-
calin and Three Potential Siderophore Bind-
ing Lipocalins, Colored by Secondary
Structure
The side chains of characteristic triads of
positively charged residues are also shown,
with interresidue distances indicated. The
representations are based on the crystal
structures of siderocalin (1L6M.pdb) and C8γ
(1IW2.pdb), the NMR structure of Q83
(1JZU.pdb), and a simplistic homology model
of Lcn12 based on siderocalin using the
SWISS-Model server (Peitsch, 1996). At 86%
sequence identity, it is presumed that Ex-
FABP will be essentially identical in structure
to Q83 at this resolution. Molecular ribbons
were generated with Chimera (Huang et al.,
1996) (www.cgl.ucsf.edu/chimera). α, orange;
β, green; and coil, gray.erocalin contributes to virulence, as the ability to syn- e
1thesize aerobactin, which does not bind to siderocalin,
is a virulence factor for enteric bacteria (Wooldridge i
(and Williams, 1993). However, it seems unusual that the
innate immune system would limit such powerful anti- h
psiderophore responses to only those pathogens whose
siderophores bind to siderocalin, cleverly degenerate (
qas it is. Since siderocalin is, to our knowledge, the first
nonbacterial siderophore binding protein characterized, e
ethe search for other candidate siderophore binders
must begin with neighboring lipocalins. Comparisons f
eshow that sequence identities rapidly plummet as the
alignments move from the siderocalins themselves. A F
anumber of neighboring lipocalins are also readily elimi-
nated as having characterized functions or ligands that t
bpreclude siderophore binding: the prostaglandin D2
synthases (Helliwell et al., 2004) (w30%–35% identical t
ato siderocalins), including distant homologs in Xenopus
and Bufo, and human HC, a lipocalin associated with i
iIgA which binds a nonsiderophore chromophore (Åker-
strom et al., 2000b) (16%–23% identical to sidero- b
Lcalins). However, given that the structural homology be-
tween even distantly related lipocalins is high and that g
othe hallmark features of the siderocalin calyx (a charac-
teristic triad of positively charged side chains) are so a
cpronounced, it is possible to identify candidate sidero-
phore binding lipocalins (“siderocalins”). g
cMurine lipocalin 12 (Lcn12, 28%–29% identical to
siderocalins) has recently been identified as a compo- i
dnent of seminal fluid (Suzuki et al., 2005), but little else
is known about its function. Simplistic homology mod- tling of Lcn12 using the SwissMODEL server (Peitsch,
996) reveals a triad of positively charged side chains
n the Lcn12 calyx completely analogous to siderocalin
Figure 5). The next most related lipocalins are the
ighly homologous (86% identical to each other) fowl
roteins Ex-FABP (Descalzi Cancedda et al., 2000)
from chicken, w20% identical to siderocalins) and
uail Q83 (Hartl et al., 2003) (20%–22% identical to sid-
rocalins). Ex-FABP is expressed during chicken
mbryo development in hypertrophic cartilage, muscle
ibers, and granulocytes and is also a component of
gg whites. In chondrocyte and myoblast cultures, Ex-
ABP expression is induced by inflammatory agents
nd inhibited by anti-inflammatory agents. Q83 is a pro-
ein strongly induced in v-myc-transformed avian fibro-
lasts, though no specific candidate ligands or func-
ions have been proposed. The NMR structure of Q83
gain shows a triad of positively-charged amino acids
n the calyx (conserved in Ex-FABP) very reminiscent,
n arrangement and character, of the key siderophore
inding residues of siderocalin (Arg81, Lys125, and
ys134), and most uncharacteristic of lipocalins in
eneral. This arrangement is also echoed in the calyx
f the more distantly related protein C8γ (Schreck et
l., 2000), a well-studied member of the complement
ascade and the subject of high-resolution crystallo-
raphic analyses (Ortlund et al., 2002). However, no
andidate ligands for C8γ have been proposed, nor has
ts precise role in the membrane attack complex been
elineated. However, particularly for C8γ, the shape of
he calyx, at least in the absence of any hypothetical
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39ligand-induced conformational changes, is incompati-
ble with the binding of any known siderocalin ligand in
a comparable geometry. Nevertheless, these observa-
tions do suggest that there may be other siderophore
binding lipocalins, currently unrecognized, perhaps
with nonoverlapping specificities, that complement the
function of siderocalin in innate immunity. Subsequent
binding and crystallographic analyses, however, fail
to convincingly demonstrate specific interactions be-
tween C8γ and any of the siderophores we have access
to (data not shown and J.M. Sodetz, personal com-
munication), showing that calyx elements beyond tri-
ads of positively charged residues may be necessary
for siderophore binding. However, a recent report
(Fluckinger et al., 2004) shows that Lcn1 (tear lipocalin,
von Ebner’s Gland protein), a lipocalin too distant in
sequence space to have been identified in this analysis,
is also functionally a “siderocalin,” broadly inhibiting
the growth of bacteria and fungi through ferric sidero-
phore sequestration, though the nature of the recogni-
tion mechanism has yet to be elucidated.
Thus, proposals to use siderophores and siderophore
analogs as therapeutics, either as antibiotics (Budzikie-
wicz, 2001; Roosenberg et al., 2000) or, through the
bound iron, as oxygen radical scavengers in various
clinical settings (Horwitz et al., 1998), will still need to
be tempered by the possibility that endogenous sidero-
phore binding specificities will limit, defeat, or con-
found such approaches.
Experimental Procedures
Protein Expression and Purification and Siderophore
Binding Assays
Human siderocalin was expressed as a glutathione S-transferase
fusion protein and purified as previously described (Bundgaard et
al., 1994; Goetz et al., 2002). Murine siderocalin was expressed in
an identical procedure. Binding of siderophores to either human or
mouse siderocalin was assayed by SPR as previously described
(Flo et al., 2004) using a Biacore System 3000 (Biacore AB) in HBS-P
buffer. Briefly, approximately 2000–5500 resonance units (RU) of
protein were coupled to research-grade CM5 sensor chips using
amine coupling chemistry following the manufacturer’s recommended
procedure. Surface-specific activities were typically greater than
75%; siderophore responses ranged from 5 to 180 RUs. Surfaces
were regenerated with 20% acetonitrile and 5 mM NaOH. A binding
call corresponds to an interaction with an estimated KD at less than
100 nM; nonbinding siderophores interact with siderocalins with a
KDs estimated to be greater than 1 mM. Siderophores were ob-
tained from Sigma-Aldrich, Biophore Research Products, or were
synthesized (Thulasiraman et al., 1998) or isolated (Lane et al.,
1995; Ratledge and Ewing, 1996) as previously described. SPR
measurements of FeEnt binding are confounded by its extreme so-
lution instability, which is not a problem for the other siderophores
listed in Figure 1. All of the binding positive compounds also copur-
ify (after extensive washing) with siderocalin, yielding obviously
colored solutions, and cocrystallize with human siderocalin, though
the resultant crystals are not always diffraction quality. FeEnt bind-
ing, the use of which is problematic in the SPR assay due to solu-
tion instability, has been previously demonstrated by alternate
means (Goetz et al., 2002).
Crystallization and Crystallography
Siderocalin was cocrystallized with four different siderophores
(TRENCAM, TRENCAM-3,2-HOPO, CMB-S, and CMB-T) using con-
ditions that accelerated crystal growth time to 2 weeks or less from
greater than 6 months (Goetz et al., 2002): vapor diffusion at 22°C
over reservoirs of 1.4–1.8 M ammonium sulfate, 50–100 mM NaCl,buffered at pH 4.5 with 100 mM Na acetate. Crystals were cryo-
preserved in a mother liquor with 20% glycerol at −170°C. The
TRENCAM complex data set was collected on a Rigaku Raxis IV
area detector using CuKα radiation; the other three data sets were
collected at beamlines 5.0.1 and 5.0.2 at the Advanced Light
Source (Lawrence Berkeley National Laboratory, Berkeley, CA). The
space group is P41212, with three monomers in the asymmetric
unit, nearly isomorphous with crystals used in the previous struc-
ture determination (Goetz et al., 2002) (Table 1). Diffraction data
were processed with DENZO and SCALEPACK. Reflections re-
served for calculating Rfree (Kleywegt and Brunger, 1996) values
were strictly matched between all three refined data sets. Model
coordinates were refined with the CNS software package (Brunger
et al., 1998) using standard protocols. Noncrystallographic symme-
try restraints were not used in the refinement, consistent with Rfree
calculations. Relevant statistics are presented in Table 1. Initial
model coordinates and target geometry for DHBA, used to model
TRENCAM-3,2-HOPO, and CMB-S/T were derived, respectively,
from the structure of enterobactin (Cambridge Structural Database
entry JOSLOS) or the structures of carboxymycobactin P (Hough
and Rogers, 1974) and sebacic acid (Cambridge Structural Data-
base entry SEBAAC).
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